Online Exclusives

Inspections

Should Remote Pharma GMP Audits End After COVID?

No matter how well a remote inspection is done, it just can't catch all the issues that may come up during a physical site visit.

George Newton, Contributing Writer 06.23.22

Biologics, Proteins, Vaccines | Cold Chain Management | Injectables | Parenterals

How to Improve the Cold Chain System in Remote Locations

Practical options for getting temperature-sensitive products to less-developed and harder-to-reach areas around the world.

Emily Newton, Contributing Writer 06.15.22

Clinical Trials | Drug Development

Advancing Patient-Focused Innovation in Oncology R&D

Jeffrey Keefer at IQVIA shares key highlights from ASCO ’22

Jeffrey Keefer, Vice President and Head, Hematology/Oncology Center of Excellence, IQVIA 06.13.22

“3 Key Trends” with Tom Wilson

Pfizer CentreOne’s Contract Manufacturing Lead offers his thought leadership.

06.09.22

Clinical Trials | Drug Development | Laboratory Testing | R&D

CRO Market Insights

PPD SMEs discuss the challenges and impact of COVID in clinical trials and the technology trends and regulatory frameworks for clinical trials today.

Kristin Brooks, Managing Editor, Contract Pharma 05.27.22

Analytical Services | Bioanalytical Services | Laboratory Testing

How Can Automation Optimize Immunohistochemistry?

Automation is beginning to emerge as an invaluable tool for multiple industries, including medicine.

Emily Newton, Contributing Writer 05.24.22

“3 Key Trends” with Joe Mase

August Bioservices’ Chief Commercial Officer offers his thought leadership.

05.24.22

Parenterals | Solid Dosage/Creams/Ointments

“3 Key Trends” with Ulrike Foley

Adare Pharma Solutions’ VP and Head of NA Business Development offers her thought leadership.

05.12.22

Clinical Trials | Information Technology

How to Evolve Your eCOA User Acceptance Testing for Trial Success

Challenges of traditional UAT, key benefits of embedded UAT, and creating a collaborative and efficient eCOA.

Kris Gustafson, Vice President and Global Head IQVIA eCOA 04.26.22

cGMP Manufacture | Cytotoxics and High Potency Manufacturing | Fill/Finish | Parenterals | Vials

Manufacturing Equipment Evolves to Address Today's Production Needs

Dr. Andreas Mattern, VP Strategy & Global Product Management Pharma at Syntegon discusses some of the latest advances in manufacturing equipment.

Kristin Brooks, Managing Editor, Contract Pharma 04.07.22

Biologics, Proteins, Vaccines | cGMP Manufacture | Drug Development | Information Technology | Scale-up/Technology Transfer

DCAT Week Innovation Leaders Program Highlights

Aamir Malik of Pfizer discusses the role of mRNA in vaccines and future drug development, partnerships, and the role of manufacturing in product innovation.

Kristin Brooks, Managing Editor, Contract Pharma 04.04.22

APIs | Drug Delivery | Excipients

INTO Launches at DCAT Week

DFE Pharma’s CEO Martti Hedman discusses the partnership established by DFE Pharma, Harro Höfliger, and Sterling, in the field of dry powder inhalation.

Kristin Brooks, Managing Editor, Contract Pharma 04.01.22

Biologics, Proteins, Vaccines | cGMP Manufacture

Manufacturing Technologies for ATMPs

Marie Jourdan of Univercells Technologies discusses manufacturing challenges and the latest advances in manufacturing equipment.

Kristin Brooks, Managing Editor, Contract Pharma 04.01.22

Biologics and Vaccine Production Drive Parenteral Market

Mike Babics of Alcami discusses key market trends and investments, vaccine development and production needs, and advances in the parenteral space.

Kristin Brooks, Managing Editor, Contract Pharma 03.30.22

Biologics, Proteins, Vaccines | cGMP Manufacture | Drug Discovery | Process Development

The Role and Benefits of Polymeric Resins in Bioprocessing

Dorie Yontz of DuPont discusses its bioprocessing offering, the role of polymeric resins, and critical elements as they relate to manufacturing.

Kristin Brooks, Managing Editor, Contract Pharma 03.14.22

cGMP Manufacture | Fill/Finish | Lyophilization | Parenterals

Industry Invests Billions in Parenteral Capabilities

Market opportunities have service providers making significant investments via acquisitions, expansion of services and capacities.

Kristin Brooks, Managing Editor, Contract Pharma 03.11.22

Biologics, Proteins, Vaccines | cGMP Manufacture | Parenterals

CDMOs Step Up Parenteral Manufacturing Support

Throughout the pandemic, CDMOs of all sizes and capabilities stepped in to provide the capabilities and capacities for the manufacture of essential medicines.

Kristin Brooks, Managing Editor, Contract Pharma 03.10.22

Clinical Trials | Drug Development | Information Technology